Exclusion Criteria:~* Normal Pressure Hydrocephalus (NPH)~* Fazekas of 3 or higher~* Morbus Huntington~*
Parkinson's disease~* HIV/AIDS~* Hepatitis C \& B~* Recent Transient Ischemic Attack (TIA) (< 2 years)~*
Cerebrovascular Accident (CVA) (< 2 years)~* TIA/CVA followed by cognitive decline (within 3 months)~* Chronic
Obstructive Pulmonary Disease (COPD) gold criteria 3 or 4 and severe asthma~* History of schizophrenia, bipolar
disorder or psychotic symptoms not otherwise specified or previous treatment for these diseases (lifetime)~*
Current radiotherapy~* Current affective disorder (i.e. anxiety or major depression)~* Cognitive problems due
to alcohol abuse, brain tumor, epilepsy, encephalitis or lack of capacity to consent to participation.~*
Current treatment with (or illicit use of) cannabis, opiates, benzodiazepines, MDMA and cocaine~* Patients with
moderate or major liver impairments will be excluded (e.g. Child-Pugh B and C).~* Use of medication showing
strong inhibition of either CYP3A4 or CYP1A2~* Patients with rare hereditary problems of galactose intolerance,
Lapp lactase deficiency or glucose-galactose malabsorption~* Patients participating in other drug studies~* If
patient does not have the possibility to be accompanied by the same informal caregiver during all test days
